1. Home
  2. NRDY vs ELTX Comparison

NRDY vs ELTX Comparison

Compare NRDY & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nerdy Inc.

NRDY

Nerdy Inc.

HOLD

Current Price

$0.94

Market Cap

127.9M

Sector

Technology

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$11.68

Market Cap

134.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRDY
ELTX
Founded
2007
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
127.9M
134.1M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
NRDY
ELTX
Price
$0.94
$11.68
Analyst Decision
Hold
Strong Buy
Analyst Count
3
1
Target Price
$1.25
$13.00
AVG Volume (30 Days)
578.4K
131.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
7.32
38.94
EPS
N/A
N/A
Revenue
N/A
$2,301,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$4.60
52 Week High
$1.90
$12.62

Technical Indicators

Market Signals
Indicator
NRDY
ELTX
Relative Strength Index (RSI) 43.65 77.12
Support Level $0.78 $10.06
Resistance Level $1.11 $12.52
Average True Range (ATR) 0.05 0.88
MACD -0.00 0.31
Stochastic Oscillator 26.39 95.84

Price Performance

Historical Comparison
NRDY
ELTX

About NRDY Nerdy Inc.

Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its proprietary platform leverages technology, including artificial intelligence ("AI"), to connect students, users, parents, guardians, and purchasers of all ages to tutors, instructors, subject matter experts, educators, and other professionals. The company provides learning experiences across numerous subjects and multiple formats, including one-on-one instruction, small group tutoring, large format classes, tutor chat, essay review, adaptive assessments, and self-study tools. The company generates revenue by selling services to learners and institutions for one-on-one instruction and small group tutoring.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

Share on Social Networks: